NCT01953523View on ClinicalTrials.gov

Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions

NACompletedINTERVENTIONAL

Enrollment

3,000

Participants

Timeline

Start Date

September 2, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

January 1, 2017

Conditions

Neurodegenerative DiseasesOsteoarthritisErectile DysfunctionAutoimmune DiseasesCardiomyopathiesEmphysema

Interventions

PROCEDURE

Administration of autologous adipose derived SVF

Intra-venous, intra-articular, and soft tissue injection delivery of SVF

Trial Locations (1)

92270

California Stem Cell Treatment Center, Rancho Mirage

All Listed Sponsors

lead

Elliot Lander

INDUSTRY

NCT01953523 - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions | Biotech Hunter | Biotech Hunter